ArticleBreast cancer research : BCR2010

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers.

Logan C Walker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.